江苏省新能源开发股份有限公司第四届董事会第十三次会议决议公告
上海证券报· 2025-09-17 04:05
证券代码:603693 证券简称:江苏新能 公告编号:2025-036 江苏省新能源开发股份有限公司 第四届董事会第十三次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 江苏省新能源开发股份有限公司(以下简称"公司")第四届董事会第十三次会议于2025年9月16日以通 讯表决的方式召开。本次会议通知已于2025年9月8日以邮件等方式发出。会议应参会董事8人,实际参 会董事8人。本次会议符合《中华人民共和国公司法》和《江苏省新能源开发股份有限公司章程》的有 关规定。 二、董事会会议审议情况 (一)审议通过《关于聘任总经理的议案》 同意聘任乔兵先生担任公司总经理,任期自董事会审议通过之日起至第四届董事会届满为止。具体内容 详见公司同日披露的《江苏省新能源开发股份有限公司关于总经理、董事辞职及聘任总经理、补选董事 的公告》(公告编号:2025-037)。 表决结果:同意8票,反对0票,弃权0票。 本议案已经公司董事会提名委员会审议通过,同意提交董事会审议。 (二)审议通过《关于补选公司第四届董事 ...
浙江荣晟环保纸业股份有限公司2025年第四次临时股东会决议公告
上海证券报· 2025-09-17 04:05
证券代码:603165 证券简称:荣晟环保 公告编号:2025-078 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示: ● 本次会议是否有否决议案:无 一、会议召开和出席情况 转债代码:113676 转债简称:荣23转债 浙江荣晟环保纸业股份有限公司 2025年第四次临时股东会决议公告 (一)股东会召开的时间:2025年9月16日 (二)股东会召开的地点:浙江省嘉兴市平湖经济技术开发区镇南东路588号公司会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况: ■ (四)表决方式是否符合《公司法》及《公司章程》的规定,股东会主持情况等。 本次股东会由公司董事会召集,冯晟宇先生主持,会议采用现场投票和网络投票相结合的方式进行表 决。本次股东会的召集和召开程序、出席会议人员资格和召集人资格、会议的表决程序及表决结果均符 合《公司法》《上市公司股东会规则》等法律、法规、规章和其他规范性文件及《公司章程》的有关规 定。 (五)公司董事和董事会秘书的出席情况 1、公司在任董事7人,出席7人; 2、董事 ...
Empire State Realty Trust Announces Dates for Third Quarter 2025 Earnings Release and Conference Call
Businesswire· 2025-09-17 04:05
NEW YORK--(BUSINESS WIRE)--Empire State Realty Trust, Inc. (NYSE: ESRT) (the "Company†), today announced that it will release its third quarter 2025 financial results on Wednesday, October 29, 2025, after the close of markets on the New York Stock Exchange. A conference call will be held on Thursday, October 30, 2025, at 12:00 p.m. Eastern Time. During the conference call, the Company's officers will review third quarter performance, discuss recent events and conduct a question-and-answer perio. ...
Wall Street hates REITs — why that might be good news for you
MarketWatch· 2025-09-17 04:05
If history is any guide, that's a positive sign for investors. ...
Aytu BioPharma to Report Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results on September 23, 2025
Accessnewswire· 2025-09-17 04:05
DENVER, CO / ACCESS Newswire / September 16, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, will report its operational and financial results for its fiscal 2025 full year and fourth quarter, after the market close on Tuesday, September 23, 2025. The Company has scheduled a conference call and webcast that same day, Tuesday, Septemb ...
IR-MED Investor Update Letter - Sept-2025
Newsfile· 2025-09-17 04:05
Rosh Pina, Israel--(Newsfile Corp. - September 16, 2025) - IR-MED Inc. (OTCQB: IRME) ("IR-MED" or the "Company"), a developer of non-invasive artificial intelligence (AI)-powered spectrographic technology to address critical healthcare challenges, today published an investor update. Dear Valued Investors,As we enter September 2025, in addition to Q2 financial reports and to the 8K recently published, I find it appropriate to update you on the developments within our Company. As you will see from the inform ...
Heidrick & Struggles to Participate in William Blair's Inaugural Human Capital Services Virtual Conference
Prnewswire· 2025-09-17 04:05
Accessibility StatementSkip Navigation Heidrick & Struggles Delivers 14% Revenue Growth in Q2, Driving Strong Profitability Heidrick & Struggles International, Inc. (Nasdaq: HSII) ("Heidrick & Struggles", "Heidrick" or the "Company"), a premier provider of global... Heidrick & Struggles to Release 2025 Second Quarter Results CHICAGO, Sept. 16, 2025 /PRNewswire/ -- Heidrick & Struggles International, Inc. (Nasdaq: HSII) ("Heidrick & Struggles", "Heidrick" or the "Company"), a premier provider of global leade ...
Neurocrine Biosciences to Present New Data from Phase 2 Study of Osavampator in Adults with Major Depressive Disorder at 38th Annual Psych Congress 2025
Prnewswire· 2025-09-17 04:05
Additional Data from SAVITRIâ"¢ Study Expand on Top-Line Results Announced in April 2024 SAVITRI Poster Presentation Chosen as Finalist for Psych Congress Poster Awards SAN DIEGO , Sept. 16, 2025 /PRNewswire/ --Â Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will present new data from the Phase 2 SAVITRI study of osavampator in adults with major depressive disorder at Psych Congress 2025, taking place September 17-21 in San Diego. ...
agilon health to Participate in the 2025 Jefferies Healthcare Services Conference
Businesswire· 2025-09-17 04:05
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that its management team will participate in a fireside chat at the 2025 Jefferies Healthcare Services Conference on Tuesday, September 30 at 8:45am ET. Interested investors and other parties may listen to a simultaneous webcast of the presentation by visiting the "Events & Presentations†section of agilon health's invest. ...
InvenTrust Properties Corp. Declares Third Quarter 2025 Cash Dividend
Businesswire· 2025-09-17 04:05
DOWNERS GROVE, Ill.--(BUSINESS WIRE)--InvenTrust Properties Corp. (NYSE: IVT) announced today that its Board of Directors declared a third quarter 2025 cash distribution of $0.2377 per share of common stock. When annualized, this is equal to a rate of $0.9508 per share. This distribution will be paid on or about October 15, 2025, to stockholders of record as of September 30, 2025. About InvenTrust Properties Corp. InvenTrust Properties Corp. is a premier Sun Belt, multi-tenant essential retail. ...